Ingenza is worked up to welcome Dr Mark Chadwick to the group as Strategic Enterprise Advisor. Mark will carry intensive trade experience to his new place at Ingenza, acquired over 30 years from a wide range of roles inside small progress corporations, overlaying the areas of biotechnology, drug discovery and drug growth.
Mark holds a PhD in Molecular Biology from the College of Newcastle, and an MBA from Imperial School London. All through his numerous skilled profession, he has gained invaluable expertise of constructing each discovery and growth companies, most notably at BioFocus – now a part of Charles River Laboratories – and at pharmaceutical providers firm Excelsyn. Mark additionally led the business group at Arcinova for 4 years, attaining a four-fold progress in gross sales and buyer base previous to the corporate’s acquisition by Quotient Sciences.
Ingenza has an illustrious observe file of engineering numerous organic programs that assist corporations of all sizes to deal with challenges in human well being and environmental sustainability. It is usually dedicated to creating inexperienced biomanufacturing processes and collectively, these elements attracted me to work with the group. I’m very a lot trying ahead to serving to Ingenza to drive their progress technique.”
Dr Mark Chadwick, Strategic Enterprise Advisor
Mark’s broad skillset will probably be a key useful resource for us as we search to turbo cost our new enterprise growth technique and prolong our collaborator community within the pharmaceutical discipline throughout discovery, growth and manufacturing areas. We’re assured Mark will play a necessary position in serving to Ingenza to proceed constructing its worldwide popularity as a number one engineering biology firm via his in-depth trade insights.”
Jaymin Amin, Chief Enterprise Officer, Ingenza.